Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

Ryerson University

$25,000.00

Ultra-sensitive sensors for the detection of onset metastatic cancers from blood samples

FY 2021-22

Summary
Cancer metastasis refers to cancer cell spread to tissues and organs beyond tumor origin and the formation of new tumors. The process is a cascade of biological events that are unclear due to its complex nature. Detecting early-stage metastasis remains challenging. Despite recent clinical treatment advances, metastasis is the most life-threatening event for cancer patients. In recent years, blood samples containing tumor and tumor stem cells, have gained intense research interest, for their possibility to accurately portray metastasis in real-time. However, sophisticated protocols of existing blood test technologies is of low sensitivity and requires isolation, a major roadblocks in detection of metastasis.This collaboration merges the technological invention of Ryerson University (RU) with findings in cancer cascading from University of Wisconsin, Milwaukee (UWM) to develop a quantum-sensor based diagnostic tool to detect cancer metastasis onset with a simple dry-lab blood test. We will investigate cancer metastasis cascades at a molecular level to identify markers for early stage cancer metastasis diagnosis. Results will have potential to radically change blood-based diagnostic approaches and create a low-cost, easy-to-operate, rapid diagnostic method that captures cancer metastasis onset with blood as a primary source of information.Findings will lead to a minimally invasive, broadly available clinical assessment tool for routine bedside use, applicable to most common types of cancer, for highly accurate point-of-care diagnosis, improving treatment outcomes, saving lives, and reducing costs of cancer treatment. New spin-off businesses to manufacture the device will generate employment opportunities in mechanical engineering and biomedical industries, strengthening Canada's economic base and economic growth.
Program
Alliance Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
571353-2021
Name nom
Venkatakrishnan, Krishnan
Department département
Mechanical and Industrial Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1
Partie
1
Nb partie
1
Application title
Ultra-sensitive sensors for the detection of onset metastatic cancers from blood samples
Keyword
NSERC
Application summary
Cancer metastasis refers to cancer cell spread to tissues and organs beyond tumor origin and the formation of new tumors. The process is a cascade of biological events that are unclear due to its complex nature. Detecting early-stage metastasis remains challenging. Despite recent clinical treatment advances, metastasis is the most life-threatening event for cancer patients. In recent years, blood samples containing tumor and tumor stem cells, have gained intense research interest, for their possibility to accurately portray metastasis in real-time. However, sophisticated protocols of existing blood test technologies is of low sensitivity and requires isolation, a major roadblocks in detection of metastasis.This collaboration merges the technological invention of Ryerson University (RU) with findings in cancer cascading from University of Wisconsin, Milwaukee (UWM) to develop a quantum-sensor based diagnostic tool to detect cancer metastasis onset with a simple dry-lab blood test. We will investigate cancer metastasis cascades at a molecular level to identify markers for early stage cancer metastasis diagnosis. Results will have potential to radically change blood-based diagnostic approaches and create a low-cost, easy-to-operate, rapid diagnostic method that captures cancer metastasis onset with blood as a primary source of information.Findings will lead to a minimally invasive, broadly available clinical assessment tool for routine bedside use, applicable to most common types of cancer, for highly accurate point-of-care diagnosis, improving treatment outcomes, saving lives, and reducing costs of cancer treatment. New spin-off businesses to manufacture the device will generate employment opportunities in mechanical engineering and biomedical industries, strengthening Canada's economic base and economic growth.
Ryerson University - $25,000 Grant (2021-22) | Canada Spends